K36 Therapeutics

Biotech · Private

Small molecule therapeutics that modulate epigenetic pathways in cancer

Claim this profile

Follows are private to you and power your alerts

Updated · k36tx.com

Sector
Biotech
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
39 pending · first 2025
Rank in peer group#481 of 1449

Capital timeline

No federal awards or Form D filings are on record for this company.

Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.

Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards

Founder? Add funding context

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#481 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 40
  • PendingBridged Heterobicyclic-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsUSPTOApplication 19410589
  • PendingPiperidinyl-methyl-purine Amine Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsUSPTOApplication 18864783
  • PendingDeuterium-enriched Piperidinyl-methyl-purine Amines And Related Compounds And Their Use In Treating Diseases And ConditionsUSPTOApplication 19368828
Show all 40 patent records
  • Bridged Heterobicyclic-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsJun 11, 2026 · Application 19410589Pending
  • Piperidinyl-methyl-purine Amine Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsJun 4, 2026 · Application 18864783Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amines And Related Compounds And Their Use In Treating Diseases And ConditionsFeb 19, 2026 · Application 19368828Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amines And Related Compounds And Their Use In Treating Diseases And ConditionsDec 9, 2025 · US 12,492,203Granted
  • Piperidinyl-methylpurine Benzenes And Related Compounds And Their Use In Treating Diseases And ConditionsNov 27, 2025 · Application 18867113Pending
  • Piperidinyl-methylpurine Pyrimidines And Related Compounds And Their Use In Treating Diseases And ConditionsJun 26, 2025 · Application 18867118Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amine Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsMay 29, 2025 · Application 18948783Pending
  • Heterobifunctional Pyridinylmethyl Aminopurine And Related Compounds And Their Use In NSD2 Degradation And Treating Medical ConditionsMay 29, 2025 · Application 18961883Pending
  • Nucleobase-substituted Piperidinyl-pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsMay 22, 2025 · Application 18954858Pending
  • Substituted Piperidinyl-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsJan 9, 2025 · Application 18750167Pending
  • Carbohydrate-functionalized Piperidinyl-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsDec 19, 2024 · Application 18735568Pending
  • Heterobicyclic-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsDec 19, 2024 · Application 18735459Pending
  • Pharmaceutical Compositions Containing A Piperidinyl-methyl-purine Amine And Their Use In Treating Diseases And ConditionsJun 27, 2024 · Application 18536781Pending
  • Piperidinyl-methyl-purine Amine D-tartaric Acid Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsJan 4, 2024 · Application 18198918Pending
  • Heterobifunctional Pyridinylmethyl Aminopurine And Related Compounds And Their Use In NSD2 Degradation And Treating Medical ConditionsApplication 63604014Pending
  • Nucleobase-substituted Piperidinyl-pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63601576Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amine Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsApplication 63600374Pending
  • Substituted Piperidinyl-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63522275Pending
  • Carbohydrate-functionalized Piperidinyl-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63471280Pending
  • Heterobicyclic-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63471279Pending
  • Piperidinyl-methylpurine Pyrimidines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication PCTUS2023023202Pending
  • Piperidinyl-methylpurine Benzenes And Related Compounds And Their Use In Treating Diseases And ConditionsApplication PCTUS2023023178Pending
  • Piperidinyl-methyl-purine Amine Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsApplication PCTUS2023022665Pending
  • Piperidinyl-methyl-purine Amine Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsApplication PCTUS2023022646Pending
  • Piperidinyl-methyl-purine Amine D-tartaric Acid Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsApplication PCTUS2023022643Pending
  • Piperidinyl-methyl-purine Amine Fumaric Acid Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsApplication PCTUS2023022656Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication PCTUS2023010204Pending
  • Pharmaceutical Compositions Containing A Piperidinyl-methyl-purine Amine And Their Use In Treating Diseases And ConditionsApplication 63431771Pending
  • Piperidinyl-methylpurine Pyrimidines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63344803Pending
  • Piperidinyl-methylpurine Benzenes And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63344794Pending
  • Piperidinyl-methyl-purine Amine D-tartaric Acid Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsApplication 63343225Pending
  • Piperidinyl-methyl-purine Amine Salts, Crystalline Forms, And Their Use In Treating Medical Diseases And ConditionsApplication 63343256Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63296676Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amine NSD2 Inhibitor Therapeutic Methods And Compositions For Treating CancerApplication PCTUS2025058142Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amine NSD2 Inhibitor Therapeutic Methods And Compositions For Treating CancerApplication 63846742Pending
  • Pharmaceutical Compositions Containing A Deuterium-enriched Piperidinyl-methyl-purine Amine And Their Use In Treating Diseases And ConditionsApplication PCTUS2025033310Pending
  • Bridged Heterobicyclic-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63808987Pending
  • Piperidinyl-methyl-purineamine NSD2 Inhibitor Therapeutic Methods And Compositions For Treating CancerApplication PCTUS2025010087Pending
  • Bridged Heterobicyclic-methylpurine Pyridines And Related Compounds And Their Use In Treating Diseases And ConditionsApplication 63729047Pending
  • Deuterium-enriched Piperidinyl-methyl-purine Amine NSD2 Inhibitor Therapeutic Methods And Compositions For Treating CancerApplication 63728006Pending
  • Cascade Prodrug Inc.Similar federal contract value in Biotech · null in contracts
  • IFM TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • Amide Technologies, Inc.Similar federal contract value in Biotech · null in contracts
  • Somnum Pharma, Inc.Similar federal contract value in Biotech · null in contracts
  • Solar Biotech, Inc.Similar federal contract value in Biotech · null in contracts
  • Nanomind, Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .